Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
Autor: | Burnett, Alan K, Russell, Nigel H, Hills, Robert K, Bowen, David, Kell, Jonathan, Knapper, Steve, Morgan, Yvonne G, Lok, Jennie, Grech, Angela, Jones, Gail, Khwaja, Asim, Friis, Lone, McMullin, Mary Frances, Hunter, Ann, Clark, Richard E, Grimwade, David |
---|---|
Zdroj: | In The Lancet Oncology October 2015 16(13):1295-1305 |
Databáze: | ScienceDirect |
Externí odkaz: |